nodes	percent_of_prediction	percent_of_DWPC	metapath
Sotalol—Isoprenaline—MAPK1—multiple sclerosis	0.015	0.912	CrCbGaD
Sotalol—KCNH2—Voltage gated Potassium channels—KCNA3—multiple sclerosis	0.00255	0.113	CbGpPWpGaD
Sotalol—Hypotension—Mitoxantrone—multiple sclerosis	0.00155	0.00161	CcSEcCtD
Sotalol—Depression—Prednisone—multiple sclerosis	0.00155	0.00161	CcSEcCtD
Sotalol—Visual impairment—Betamethasone—multiple sclerosis	0.00154	0.0016	CcSEcCtD
Sotalol—Visual impairment—Dexamethasone—multiple sclerosis	0.00154	0.0016	CcSEcCtD
Sotalol—Acute coronary syndrome—Prednisone—multiple sclerosis	0.00153	0.00159	CcSEcCtD
Sotalol—Neuropathy peripheral—Prednisone—multiple sclerosis	0.00152	0.00158	CcSEcCtD
Sotalol—Myocardial infarction—Prednisone—multiple sclerosis	0.00152	0.00158	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.00151	0.00157	CcSEcCtD
Sotalol—Dysgeusia—Triamcinolone—multiple sclerosis	0.0015	0.00156	CcSEcCtD
Sotalol—Nausea—Cladribine—multiple sclerosis	0.0015	0.00156	CcSEcCtD
Sotalol—Vertigo—Prednisolone—multiple sclerosis	0.0015	0.00156	CcSEcCtD
Sotalol—Syncope—Prednisolone—multiple sclerosis	0.0015	0.00156	CcSEcCtD
Sotalol—Paraesthesia—Mitoxantrone—multiple sclerosis	0.00149	0.00155	CcSEcCtD
Sotalol—Back pain—Triamcinolone—multiple sclerosis	0.00148	0.00154	CcSEcCtD
Sotalol—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00148	0.00154	CcSEcCtD
Sotalol—Somnolence—Mitoxantrone—multiple sclerosis	0.00148	0.00154	CcSEcCtD
Sotalol—Loss of consciousness—Prednisolone—multiple sclerosis	0.00147	0.00153	CcSEcCtD
Sotalol—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00146	0.00152	CcSEcCtD
Sotalol—Asthma—Methotrexate—multiple sclerosis	0.00145	0.00151	CcSEcCtD
Sotalol—Angiopathy—Dexamethasone—multiple sclerosis	0.00145	0.00151	CcSEcCtD
Sotalol—Angiopathy—Betamethasone—multiple sclerosis	0.00145	0.00151	CcSEcCtD
Sotalol—Ibuprofen—ALB—multiple sclerosis	0.00145	0.0882	CrCbGaD
Sotalol—Decreased appetite—Mitoxantrone—multiple sclerosis	0.00144	0.0015	CcSEcCtD
Sotalol—Hypertension—Prednisolone—multiple sclerosis	0.00144	0.0015	CcSEcCtD
Sotalol—Eosinophilia—Methotrexate—multiple sclerosis	0.00144	0.0015	CcSEcCtD
Sotalol—Fatigue—Mitoxantrone—multiple sclerosis	0.00143	0.00149	CcSEcCtD
Sotalol—Arrhythmia—Dexamethasone—multiple sclerosis	0.00143	0.00149	CcSEcCtD
Sotalol—Arrhythmia—Betamethasone—multiple sclerosis	0.00143	0.00149	CcSEcCtD
Sotalol—Pain—Mitoxantrone—multiple sclerosis	0.00142	0.00148	CcSEcCtD
Sotalol—Bradycardia—Prednisone—multiple sclerosis	0.00142	0.00148	CcSEcCtD
Sotalol—Alopecia—Dexamethasone—multiple sclerosis	0.00141	0.00147	CcSEcCtD
Sotalol—Alopecia—Betamethasone—multiple sclerosis	0.00141	0.00147	CcSEcCtD
Sotalol—Diarrhoea—Azathioprine—multiple sclerosis	0.00141	0.00146	CcSEcCtD
Sotalol—Haemoglobin—Prednisone—multiple sclerosis	0.0014	0.00146	CcSEcCtD
Sotalol—Haemorrhage—Prednisone—multiple sclerosis	0.00139	0.00145	CcSEcCtD
Sotalol—Vertigo—Triamcinolone—multiple sclerosis	0.00138	0.00143	CcSEcCtD
Sotalol—Syncope—Triamcinolone—multiple sclerosis	0.00138	0.00143	CcSEcCtD
Sotalol—Vertigo—Methylprednisolone—multiple sclerosis	0.00138	0.00143	CcSEcCtD
Sotalol—Syncope—Methylprednisolone—multiple sclerosis	0.00137	0.00143	CcSEcCtD
Sotalol—Oedema—Prednisolone—multiple sclerosis	0.00136	0.00142	CcSEcCtD
Sotalol—Dizziness—Azathioprine—multiple sclerosis	0.00136	0.00141	CcSEcCtD
Sotalol—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00136	0.00141	CcSEcCtD
Sotalol—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.00135	0.00141	CcSEcCtD
Sotalol—Loss of consciousness—Triamcinolone—multiple sclerosis	0.00135	0.0014	CcSEcCtD
Sotalol—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.00135	0.0014	CcSEcCtD
Sotalol—Shock—Prednisolone—multiple sclerosis	0.00134	0.00139	CcSEcCtD
Sotalol—Cough—Triamcinolone—multiple sclerosis	0.00134	0.00139	CcSEcCtD
Sotalol—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.00133	0.00138	CcSEcCtD
Sotalol—Hypertension—Triamcinolone—multiple sclerosis	0.00133	0.00138	CcSEcCtD
Sotalol—Hypertension—Methylprednisolone—multiple sclerosis	0.00132	0.00138	CcSEcCtD
Sotalol—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00132	0.00137	CcSEcCtD
Sotalol—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00131	0.00137	CcSEcCtD
Sotalol—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00131	0.00137	CcSEcCtD
Sotalol—KCNH2—Potassium Channels—KCNA3—multiple sclerosis	0.00131	0.0582	CbGpPWpGaD
Sotalol—Myalgia—Triamcinolone—multiple sclerosis	0.00131	0.00136	CcSEcCtD
Sotalol—Vomiting—Azathioprine—multiple sclerosis	0.00131	0.00136	CcSEcCtD
Sotalol—Myalgia—Methylprednisolone—multiple sclerosis	0.0013	0.00136	CcSEcCtD
Sotalol—Anxiety—Methylprednisolone—multiple sclerosis	0.0013	0.00135	CcSEcCtD
Sotalol—Drowsiness—Methotrexate—multiple sclerosis	0.0013	0.00135	CcSEcCtD
Sotalol—Rash—Azathioprine—multiple sclerosis	0.0013	0.00135	CcSEcCtD
Sotalol—Dermatitis—Azathioprine—multiple sclerosis	0.00129	0.00135	CcSEcCtD
Sotalol—Depression—Methotrexate—multiple sclerosis	0.00129	0.00135	CcSEcCtD
Sotalol—Headache—Azathioprine—multiple sclerosis	0.00129	0.00134	CcSEcCtD
Sotalol—Angiopathy—Prednisone—multiple sclerosis	0.00126	0.00132	CcSEcCtD
Sotalol—Oedema—Triamcinolone—multiple sclerosis	0.00125	0.0013	CcSEcCtD
Sotalol—Vertigo—Betamethasone—multiple sclerosis	0.00125	0.0013	CcSEcCtD
Sotalol—Vertigo—Dexamethasone—multiple sclerosis	0.00125	0.0013	CcSEcCtD
Sotalol—Syncope—Betamethasone—multiple sclerosis	0.00125	0.0013	CcSEcCtD
Sotalol—Syncope—Dexamethasone—multiple sclerosis	0.00125	0.0013	CcSEcCtD
Sotalol—Arrhythmia—Prednisone—multiple sclerosis	0.00124	0.0013	CcSEcCtD
Sotalol—Infection—Triamcinolone—multiple sclerosis	0.00124	0.00129	CcSEcCtD
Sotalol—Infection—Methylprednisolone—multiple sclerosis	0.00124	0.00129	CcSEcCtD
Sotalol—Shock—Triamcinolone—multiple sclerosis	0.00123	0.00128	CcSEcCtD
Sotalol—Insomnia—Prednisolone—multiple sclerosis	0.00123	0.00128	CcSEcCtD
Sotalol—Alopecia—Prednisone—multiple sclerosis	0.00123	0.00128	CcSEcCtD
Sotalol—Shock—Methylprednisolone—multiple sclerosis	0.00123	0.00128	CcSEcCtD
Sotalol—Loss of consciousness—Dexamethasone—multiple sclerosis	0.00122	0.00127	CcSEcCtD
Sotalol—Loss of consciousness—Betamethasone—multiple sclerosis	0.00122	0.00127	CcSEcCtD
Sotalol—Paraesthesia—Prednisolone—multiple sclerosis	0.00122	0.00127	CcSEcCtD
Sotalol—Nausea—Azathioprine—multiple sclerosis	0.00122	0.00127	CcSEcCtD
Sotalol—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00121	0.00126	CcSEcCtD
Sotalol—Agranulocytosis—Methotrexate—multiple sclerosis	0.00121	0.00126	CcSEcCtD
Sotalol—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00121	0.00126	CcSEcCtD
Sotalol—Hypertension—Dexamethasone—multiple sclerosis	0.0012	0.00125	CcSEcCtD
Sotalol—Hypertension—Betamethasone—multiple sclerosis	0.0012	0.00125	CcSEcCtD
Sotalol—KCNH2—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.0012	0.0534	CbGpPWpGaD
Sotalol—Asthenia—Mitoxantrone—multiple sclerosis	0.00119	0.00124	CcSEcCtD
Sotalol—Myalgia—Betamethasone—multiple sclerosis	0.00119	0.00123	CcSEcCtD
Sotalol—Myalgia—Dexamethasone—multiple sclerosis	0.00119	0.00123	CcSEcCtD
Sotalol—Anxiety—Dexamethasone—multiple sclerosis	0.00118	0.00123	CcSEcCtD
Sotalol—Anxiety—Betamethasone—multiple sclerosis	0.00118	0.00123	CcSEcCtD
Sotalol—Haemoglobin—Methotrexate—multiple sclerosis	0.00117	0.00122	CcSEcCtD
Sotalol—Hypotension—Methylprednisolone—multiple sclerosis	0.00117	0.00122	CcSEcCtD
Sotalol—Pain—Prednisolone—multiple sclerosis	0.00116	0.00121	CcSEcCtD
Sotalol—Haemorrhage—Methotrexate—multiple sclerosis	0.00116	0.00121	CcSEcCtD
Sotalol—Vision blurred—Prednisone—multiple sclerosis	0.00114	0.00119	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.00114	0.00119	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.00114	0.00118	CcSEcCtD
Sotalol—Oedema—Betamethasone—multiple sclerosis	0.00114	0.00118	CcSEcCtD
Sotalol—Oedema—Dexamethasone—multiple sclerosis	0.00114	0.00118	CcSEcCtD
Sotalol—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00114	0.00118	CcSEcCtD
Sotalol—Insomnia—Triamcinolone—multiple sclerosis	0.00113	0.00118	CcSEcCtD
Sotalol—Insomnia—Methylprednisolone—multiple sclerosis	0.00113	0.00118	CcSEcCtD
Sotalol—Infection—Dexamethasone—multiple sclerosis	0.00113	0.00117	CcSEcCtD
Sotalol—Infection—Betamethasone—multiple sclerosis	0.00113	0.00117	CcSEcCtD
Sotalol—Paraesthesia—Triamcinolone—multiple sclerosis	0.00112	0.00117	CcSEcCtD
Sotalol—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00112	0.00117	CcSEcCtD
Sotalol—Visual impairment—Methotrexate—multiple sclerosis	0.00112	0.00117	CcSEcCtD
Sotalol—Shock—Dexamethasone—multiple sclerosis	0.00112	0.00116	CcSEcCtD
Sotalol—Shock—Betamethasone—multiple sclerosis	0.00112	0.00116	CcSEcCtD
Sotalol—Dyspnoea—Triamcinolone—multiple sclerosis	0.00112	0.00116	CcSEcCtD
Sotalol—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.00111	0.00116	CcSEcCtD
Sotalol—Thrombocytopenia—Betamethasone—multiple sclerosis	0.00111	0.00116	CcSEcCtD
Sotalol—Dyspepsia—Triamcinolone—multiple sclerosis	0.0011	0.00115	CcSEcCtD
Sotalol—Dyspepsia—Methylprednisolone—multiple sclerosis	0.0011	0.00114	CcSEcCtD
Sotalol—Hyperhidrosis—Betamethasone—multiple sclerosis	0.0011	0.00114	CcSEcCtD
Sotalol—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.0011	0.00114	CcSEcCtD
Sotalol—Vertigo—Prednisone—multiple sclerosis	0.00109	0.00113	CcSEcCtD
Sotalol—Syncope—Prednisone—multiple sclerosis	0.00109	0.00113	CcSEcCtD
Sotalol—Fatigue—Triamcinolone—multiple sclerosis	0.00108	0.00112	CcSEcCtD
Sotalol—Fatigue—Methylprednisolone—multiple sclerosis	0.00108	0.00112	CcSEcCtD
Sotalol—Pain—Triamcinolone—multiple sclerosis	0.00107	0.00111	CcSEcCtD
Sotalol—Loss of consciousness—Prednisone—multiple sclerosis	0.00107	0.00111	CcSEcCtD
Sotalol—Hypotension—Dexamethasone—multiple sclerosis	0.00106	0.00111	CcSEcCtD
Sotalol—Hypotension—Betamethasone—multiple sclerosis	0.00106	0.00111	CcSEcCtD
Sotalol—Angiopathy—Methotrexate—multiple sclerosis	0.00106	0.0011	CcSEcCtD
Sotalol—Vomiting—Mitoxantrone—multiple sclerosis	0.00106	0.0011	CcSEcCtD
Sotalol—Hypertension—Prednisone—multiple sclerosis	0.00105	0.00109	CcSEcCtD
Sotalol—Rash—Mitoxantrone—multiple sclerosis	0.00105	0.00109	CcSEcCtD
Sotalol—Dermatitis—Mitoxantrone—multiple sclerosis	0.00105	0.00109	CcSEcCtD
Sotalol—Headache—Mitoxantrone—multiple sclerosis	0.00104	0.00108	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00104	0.00108	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00104	0.00108	CcSEcCtD
Sotalol—Myalgia—Prednisone—multiple sclerosis	0.00103	0.00107	CcSEcCtD
Sotalol—Anxiety—Prednisone—multiple sclerosis	0.00103	0.00107	CcSEcCtD
Sotalol—Alopecia—Methotrexate—multiple sclerosis	0.00103	0.00107	CcSEcCtD
Sotalol—Insomnia—Dexamethasone—multiple sclerosis	0.00103	0.00107	CcSEcCtD
Sotalol—Insomnia—Betamethasone—multiple sclerosis	0.00103	0.00107	CcSEcCtD
Sotalol—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00102	0.00106	CcSEcCtD
Sotalol—Paraesthesia—Betamethasone—multiple sclerosis	0.00102	0.00106	CcSEcCtD
Sotalol—Paraesthesia—Dexamethasone—multiple sclerosis	0.00102	0.00106	CcSEcCtD
Sotalol—Dyspepsia—Betamethasone—multiple sclerosis	0.001	0.00104	CcSEcCtD
Sotalol—Dyspepsia—Dexamethasone—multiple sclerosis	0.001	0.00104	CcSEcCtD
Sotalol—Dysgeusia—Methotrexate—multiple sclerosis	0.000993	0.00103	CcSEcCtD
Sotalol—Body temperature increased—Triamcinolone—multiple sclerosis	0.00099	0.00103	CcSEcCtD
Sotalol—Oedema—Prednisone—multiple sclerosis	0.00099	0.00103	CcSEcCtD
Sotalol—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000988	0.00103	CcSEcCtD
Sotalol—Decreased appetite—Dexamethasone—multiple sclerosis	0.000988	0.00103	CcSEcCtD
Sotalol—Decreased appetite—Betamethasone—multiple sclerosis	0.000988	0.00103	CcSEcCtD
Sotalol—Nausea—Mitoxantrone—multiple sclerosis	0.000986	0.00103	CcSEcCtD
Sotalol—Infection—Prednisone—multiple sclerosis	0.000983	0.00102	CcSEcCtD
Sotalol—Back pain—Methotrexate—multiple sclerosis	0.00098	0.00102	CcSEcCtD
Sotalol—Fatigue—Dexamethasone—multiple sclerosis	0.00098	0.00102	CcSEcCtD
Sotalol—Fatigue—Betamethasone—multiple sclerosis	0.00098	0.00102	CcSEcCtD
Sotalol—Shock—Prednisone—multiple sclerosis	0.000974	0.00101	CcSEcCtD
Sotalol—Pain—Dexamethasone—multiple sclerosis	0.000972	0.00101	CcSEcCtD
Sotalol—Pain—Betamethasone—multiple sclerosis	0.000972	0.00101	CcSEcCtD
Sotalol—Hyperhidrosis—Prednisone—multiple sclerosis	0.000957	0.000996	CcSEcCtD
Sotalol—Vision blurred—Methotrexate—multiple sclerosis	0.000955	0.000994	CcSEcCtD
Sotalol—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000929	0.000967	CcSEcCtD
Sotalol—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000929	0.000967	CcSEcCtD
Sotalol—Vertigo—Methotrexate—multiple sclerosis	0.000911	0.000948	CcSEcCtD
Sotalol—Leukopenia—Methotrexate—multiple sclerosis	0.000907	0.000944	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000902	0.000938	CcSEcCtD
Sotalol—Dizziness—Prednisolone—multiple sclerosis	0.000901	0.000937	CcSEcCtD
Sotalol—Asthenia—Triamcinolone—multiple sclerosis	0.000899	0.000935	CcSEcCtD
Sotalol—Body temperature increased—Dexamethasone—multiple sclerosis	0.000899	0.000935	CcSEcCtD
Sotalol—Body temperature increased—Betamethasone—multiple sclerosis	0.000899	0.000935	CcSEcCtD
Sotalol—Abdominal pain—Betamethasone—multiple sclerosis	0.000899	0.000935	CcSEcCtD
Sotalol—Abdominal pain—Dexamethasone—multiple sclerosis	0.000899	0.000935	CcSEcCtD
Sotalol—Asthenia—Methylprednisolone—multiple sclerosis	0.000897	0.000933	CcSEcCtD
Sotalol—Insomnia—Prednisone—multiple sclerosis	0.000895	0.000932	CcSEcCtD
Sotalol—Paraesthesia—Prednisone—multiple sclerosis	0.000889	0.000925	CcSEcCtD
Sotalol—Pruritus—Triamcinolone—multiple sclerosis	0.000886	0.000922	CcSEcCtD
Sotalol—Cough—Methotrexate—multiple sclerosis	0.000885	0.00092	CcSEcCtD
Sotalol—Pruritus—Methylprednisolone—multiple sclerosis	0.000884	0.00092	CcSEcCtD
Sotalol—Dyspepsia—Prednisone—multiple sclerosis	0.000871	0.000907	CcSEcCtD
Sotalol—Chest pain—Methotrexate—multiple sclerosis	0.000863	0.000898	CcSEcCtD
Sotalol—Myalgia—Methotrexate—multiple sclerosis	0.000863	0.000898	CcSEcCtD
Sotalol—Decreased appetite—Prednisone—multiple sclerosis	0.00086	0.000895	CcSEcCtD
Sotalol—Rash—Prednisolone—multiple sclerosis	0.000859	0.000894	CcSEcCtD
Sotalol—Dermatitis—Prednisolone—multiple sclerosis	0.000858	0.000893	CcSEcCtD
Sotalol—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000855	0.00089	CcSEcCtD
Sotalol—Fatigue—Prednisone—multiple sclerosis	0.000853	0.000888	CcSEcCtD
Sotalol—Headache—Prednisolone—multiple sclerosis	0.000853	0.000888	CcSEcCtD
Sotalol—Dizziness—Triamcinolone—multiple sclerosis	0.000828	0.000862	CcSEcCtD
Sotalol—Dizziness—Methylprednisolone—multiple sclerosis	0.000827	0.00086	CcSEcCtD
Sotalol—Infection—Methotrexate—multiple sclerosis	0.000822	0.000855	CcSEcCtD
Sotalol—Asthenia—Dexamethasone—multiple sclerosis	0.000816	0.000849	CcSEcCtD
Sotalol—Asthenia—Betamethasone—multiple sclerosis	0.000816	0.000849	CcSEcCtD
Sotalol—Thrombocytopenia—Methotrexate—multiple sclerosis	0.00081	0.000843	CcSEcCtD
Sotalol—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000809	0.000842	CcSEcCtD
Sotalol—Nausea—Prednisolone—multiple sclerosis	0.000809	0.000842	CcSEcCtD
Sotalol—Pruritus—Dexamethasone—multiple sclerosis	0.000804	0.000837	CcSEcCtD
Sotalol—Pruritus—Betamethasone—multiple sclerosis	0.000804	0.000837	CcSEcCtD
Sotalol—Hyperhidrosis—Methotrexate—multiple sclerosis	0.0008	0.000832	CcSEcCtD
Sotalol—Vomiting—Triamcinolone—multiple sclerosis	0.000796	0.000829	CcSEcCtD
Sotalol—Vomiting—Methylprednisolone—multiple sclerosis	0.000795	0.000827	CcSEcCtD
Sotalol—Rash—Triamcinolone—multiple sclerosis	0.00079	0.000822	CcSEcCtD
Sotalol—Dermatitis—Triamcinolone—multiple sclerosis	0.000789	0.000821	CcSEcCtD
Sotalol—Rash—Methylprednisolone—multiple sclerosis	0.000788	0.00082	CcSEcCtD
Sotalol—Dermatitis—Methylprednisolone—multiple sclerosis	0.000787	0.000819	CcSEcCtD
Sotalol—Headache—Triamcinolone—multiple sclerosis	0.000785	0.000817	CcSEcCtD
Sotalol—Headache—Methylprednisolone—multiple sclerosis	0.000783	0.000815	CcSEcCtD
Sotalol—Abdominal pain—Prednisone—multiple sclerosis	0.000783	0.000814	CcSEcCtD
Sotalol—Body temperature increased—Prednisone—multiple sclerosis	0.000783	0.000814	CcSEcCtD
Sotalol—Diarrhoea—Dexamethasone—multiple sclerosis	0.000778	0.000809	CcSEcCtD
Sotalol—Diarrhoea—Betamethasone—multiple sclerosis	0.000778	0.000809	CcSEcCtD
Sotalol—Hypotension—Methotrexate—multiple sclerosis	0.000773	0.000804	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000754	0.000784	CcSEcCtD
Sotalol—Dizziness—Dexamethasone—multiple sclerosis	0.000752	0.000782	CcSEcCtD
Sotalol—Dizziness—Betamethasone—multiple sclerosis	0.000752	0.000782	CcSEcCtD
Sotalol—Insomnia—Methotrexate—multiple sclerosis	0.000748	0.000779	CcSEcCtD
Sotalol—Nausea—Triamcinolone—multiple sclerosis	0.000744	0.000774	CcSEcCtD
Sotalol—Paraesthesia—Methotrexate—multiple sclerosis	0.000743	0.000773	CcSEcCtD
Sotalol—Nausea—Methylprednisolone—multiple sclerosis	0.000742	0.000773	CcSEcCtD
Sotalol—Dyspnoea—Methotrexate—multiple sclerosis	0.000738	0.000767	CcSEcCtD
Sotalol—Somnolence—Methotrexate—multiple sclerosis	0.000735	0.000765	CcSEcCtD
Sotalol—Dyspepsia—Methotrexate—multiple sclerosis	0.000728	0.000758	CcSEcCtD
Sotalol—Vomiting—Betamethasone—multiple sclerosis	0.000723	0.000752	CcSEcCtD
Sotalol—Vomiting—Dexamethasone—multiple sclerosis	0.000723	0.000752	CcSEcCtD
Sotalol—Decreased appetite—Methotrexate—multiple sclerosis	0.000719	0.000748	CcSEcCtD
Sotalol—Rash—Betamethasone—multiple sclerosis	0.000717	0.000746	CcSEcCtD
Sotalol—Rash—Dexamethasone—multiple sclerosis	0.000717	0.000746	CcSEcCtD
Sotalol—Dermatitis—Dexamethasone—multiple sclerosis	0.000716	0.000745	CcSEcCtD
Sotalol—Dermatitis—Betamethasone—multiple sclerosis	0.000716	0.000745	CcSEcCtD
Sotalol—Fatigue—Methotrexate—multiple sclerosis	0.000713	0.000742	CcSEcCtD
Sotalol—Headache—Dexamethasone—multiple sclerosis	0.000712	0.000741	CcSEcCtD
Sotalol—Headache—Betamethasone—multiple sclerosis	0.000712	0.000741	CcSEcCtD
Sotalol—Asthenia—Prednisone—multiple sclerosis	0.00071	0.000739	CcSEcCtD
Sotalol—Pain—Methotrexate—multiple sclerosis	0.000707	0.000736	CcSEcCtD
Sotalol—Pruritus—Prednisone—multiple sclerosis	0.0007	0.000729	CcSEcCtD
Sotalol—Diarrhoea—Prednisone—multiple sclerosis	0.000677	0.000705	CcSEcCtD
Sotalol—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000676	0.000704	CcSEcCtD
Sotalol—Nausea—Betamethasone—multiple sclerosis	0.000675	0.000703	CcSEcCtD
Sotalol—Nausea—Dexamethasone—multiple sclerosis	0.000675	0.000703	CcSEcCtD
Sotalol—Dizziness—Prednisone—multiple sclerosis	0.000655	0.000681	CcSEcCtD
Sotalol—Abdominal pain—Methotrexate—multiple sclerosis	0.000654	0.00068	CcSEcCtD
Sotalol—Body temperature increased—Methotrexate—multiple sclerosis	0.000654	0.00068	CcSEcCtD
Sotalol—Vomiting—Prednisone—multiple sclerosis	0.000629	0.000655	CcSEcCtD
Sotalol—Rash—Prednisone—multiple sclerosis	0.000624	0.000649	CcSEcCtD
Sotalol—Dermatitis—Prednisone—multiple sclerosis	0.000624	0.000649	CcSEcCtD
Sotalol—Headache—Prednisone—multiple sclerosis	0.00062	0.000645	CcSEcCtD
Sotalol—Asthenia—Methotrexate—multiple sclerosis	0.000594	0.000618	CcSEcCtD
Sotalol—Nausea—Prednisone—multiple sclerosis	0.000588	0.000612	CcSEcCtD
Sotalol—Pruritus—Methotrexate—multiple sclerosis	0.000585	0.000609	CcSEcCtD
Sotalol—KCNH2—Neuronal System—KCNA3—multiple sclerosis	0.000571	0.0254	CbGpPWpGaD
Sotalol—Diarrhoea—Methotrexate—multiple sclerosis	0.000566	0.000589	CcSEcCtD
Sotalol—Dizziness—Methotrexate—multiple sclerosis	0.000547	0.000569	CcSEcCtD
Sotalol—ADRB2—GPCRs, Other—S1PR1—multiple sclerosis	0.000544	0.0242	CbGpPWpGaD
Sotalol—Vomiting—Methotrexate—multiple sclerosis	0.000526	0.000547	CcSEcCtD
Sotalol—Rash—Methotrexate—multiple sclerosis	0.000522	0.000543	CcSEcCtD
Sotalol—Dermatitis—Methotrexate—multiple sclerosis	0.000521	0.000542	CcSEcCtD
Sotalol—Headache—Methotrexate—multiple sclerosis	0.000518	0.000539	CcSEcCtD
Sotalol—KCNH2—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.000499	0.0222	CbGpPWpGaD
Sotalol—Nausea—Methotrexate—multiple sclerosis	0.000491	0.000511	CcSEcCtD
Sotalol—ADRB2—Arf6 trafficking events—ITGA4—multiple sclerosis	0.000408	0.0181	CbGpPWpGaD
Sotalol—ADRB1—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000387	0.0172	CbGpPWpGaD
Sotalol—KCNH2—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000378	0.0168	CbGpPWpGaD
Sotalol—ADRB1—Calcium Regulation in the Cardiac Cell—RGS1—multiple sclerosis	0.000319	0.0142	CbGpPWpGaD
Sotalol—ADRB2—Calcium Regulation in the Cardiac Cell—RGS1—multiple sclerosis	0.000312	0.0139	CbGpPWpGaD
Sotalol—KCNH2—Hematopoietic Stem Cell Differentiation—IL1B—multiple sclerosis	0.000291	0.0129	CbGpPWpGaD
Sotalol—ADRB2—GPCRs, Other—CXCR3—multiple sclerosis	0.000266	0.0118	CbGpPWpGaD
Sotalol—ADRB2—GPCRs, Other—CNR1—multiple sclerosis	0.000239	0.0106	CbGpPWpGaD
Sotalol—ADRB1—G alpha (s) signalling events—PTGER4—multiple sclerosis	0.00022	0.00976	CbGpPWpGaD
Sotalol—ADRB2—G alpha (s) signalling events—PTGER4—multiple sclerosis	0.000215	0.00955	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.000207	0.0092	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.000203	0.009	CbGpPWpGaD
Sotalol—KCNH2—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000195	0.00869	CbGpPWpGaD
Sotalol—ADRB1—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.000195	0.00866	CbGpPWpGaD
Sotalol—ADRB2—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.000191	0.00847	CbGpPWpGaD
Sotalol—KCNH2—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000187	0.00829	CbGpPWpGaD
Sotalol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.000178	0.00792	CbGpPWpGaD
Sotalol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.000174	0.00775	CbGpPWpGaD
Sotalol—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—multiple sclerosis	0.00017	0.00757	CbGpPWpGaD
Sotalol—ADRB1—Endothelin Pathways—MAPK1—multiple sclerosis	0.000169	0.00753	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.000167	0.00742	CbGpPWpGaD
Sotalol—ADRB2—GPCRs, Other—CCR5—multiple sclerosis	0.000167	0.00741	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.000163	0.00726	CbGpPWpGaD
Sotalol—KCNH2—Neuronal System—BCHE—multiple sclerosis	0.00016	0.00712	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—S1PR1—multiple sclerosis	0.000158	0.00701	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—S1PR1—multiple sclerosis	0.000154	0.00686	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.000153	0.00679	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.000153	0.00679	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.000149	0.00664	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.000149	0.00664	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—GPR65—multiple sclerosis	0.000127	0.00565	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—GPR65—multiple sclerosis	0.000124	0.00553	CbGpPWpGaD
Sotalol—ADRB1—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.000122	0.00543	CbGpPWpGaD
Sotalol—ADRB2—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.00012	0.00531	CbGpPWpGaD
Sotalol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.000118	0.00525	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—CXCL13—multiple sclerosis	0.000116	0.00517	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—CCR1—multiple sclerosis	0.000116	0.00517	CbGpPWpGaD
Sotalol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.000115	0.00513	CbGpPWpGaD
Sotalol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.000115	0.0051	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—CCR1—multiple sclerosis	0.000114	0.00505	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—CXCL13—multiple sclerosis	0.000114	0.00505	CbGpPWpGaD
Sotalol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.000112	0.00499	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.000109	0.00484	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.000106	0.00473	CbGpPWpGaD
Sotalol—ADRB1—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.000106	0.00471	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.000105	0.00465	CbGpPWpGaD
Sotalol—ADRB1—G alpha (s) signalling events—POMC—multiple sclerosis	0.000104	0.00462	CbGpPWpGaD
Sotalol—ADRB2—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.000104	0.00461	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.000102	0.00455	CbGpPWpGaD
Sotalol—ADRB2—G alpha (s) signalling events—POMC—multiple sclerosis	0.000102	0.00452	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000101	0.0045	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	9.89e-05	0.0044	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	9.84e-05	0.00437	CbGpPWpGaD
Sotalol—KCNH2—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	9.79e-05	0.00435	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	9.62e-05	0.00428	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	9.08e-05	0.00404	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—S1PR1—multiple sclerosis	8.91e-05	0.00396	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	8.88e-05	0.00395	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—S1PR1—multiple sclerosis	8.72e-05	0.00387	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—CCL3—multiple sclerosis	8.28e-05	0.00368	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	8.18e-05	0.00363	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—CCL3—multiple sclerosis	8.1e-05	0.0036	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—S1PR1—multiple sclerosis	8.09e-05	0.0036	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	8e-05	0.00355	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—PTGER4—multiple sclerosis	7.97e-05	0.00354	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—S1PR1—multiple sclerosis	7.92e-05	0.00352	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—PTGER4—multiple sclerosis	7.8e-05	0.00347	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—CXCR3—multiple sclerosis	7.7e-05	0.00342	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—RGS1—multiple sclerosis	7.58e-05	0.00337	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—CXCR3—multiple sclerosis	7.53e-05	0.00335	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—CCR2—multiple sclerosis	7.49e-05	0.00333	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—RGS1—multiple sclerosis	7.41e-05	0.00329	CbGpPWpGaD
Sotalol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	7.4e-05	0.00329	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—CCR2—multiple sclerosis	7.33e-05	0.00326	CbGpPWpGaD
Sotalol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	7.24e-05	0.00322	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—GPR65—multiple sclerosis	7.18e-05	0.00319	CbGpPWpGaD
Sotalol—KCNH2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	7.1e-05	0.00316	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	7.04e-05	0.00313	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—GPR65—multiple sclerosis	7.03e-05	0.00312	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—CNR1—multiple sclerosis	6.91e-05	0.00307	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	6.88e-05	0.00306	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—RGS1—multiple sclerosis	6.88e-05	0.00306	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—CNR1—multiple sclerosis	6.76e-05	0.00301	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—RGS1—multiple sclerosis	6.73e-05	0.00299	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CCR1—multiple sclerosis	6.57e-05	0.00292	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CXCL13—multiple sclerosis	6.57e-05	0.00292	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—GPR65—multiple sclerosis	6.52e-05	0.0029	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CCR1—multiple sclerosis	6.43e-05	0.00286	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CXCL13—multiple sclerosis	6.43e-05	0.00286	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—GPR65—multiple sclerosis	6.38e-05	0.00284	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	6.34e-05	0.00282	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—LINGO1—multiple sclerosis	6.31e-05	0.0028	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—CXCL10—multiple sclerosis	6.23e-05	0.00277	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	6.2e-05	0.00276	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—LINGO1—multiple sclerosis	6.17e-05	0.00274	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—CXCL10—multiple sclerosis	6.09e-05	0.00271	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CXCL13—multiple sclerosis	5.97e-05	0.00265	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CCR1—multiple sclerosis	5.97e-05	0.00265	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CCR1—multiple sclerosis	5.84e-05	0.00259	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CXCL13—multiple sclerosis	5.84e-05	0.00259	CbGpPWpGaD
Sotalol—KCNH2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	5.73e-05	0.00255	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TAGAP—multiple sclerosis	5.47e-05	0.00243	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—CCL5—multiple sclerosis	5.36e-05	0.00238	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TAGAP—multiple sclerosis	5.35e-05	0.00238	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—CCL5—multiple sclerosis	5.24e-05	0.00233	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	4.96e-05	0.0022	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	4.85e-05	0.00215	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	4.85e-05	0.00215	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—CCR5—multiple sclerosis	4.83e-05	0.00215	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—S1PR1—multiple sclerosis	4.78e-05	0.00212	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	4.74e-05	0.00211	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—CCR5—multiple sclerosis	4.72e-05	0.0021	CbGpPWpGaD
Sotalol—KCNH2—Neuronal System—MAPK1—multiple sclerosis	4.68e-05	0.00208	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—S1PR1—multiple sclerosis	4.68e-05	0.00208	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GPC5—multiple sclerosis	4.65e-05	0.00207	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GPC5—multiple sclerosis	4.55e-05	0.00202	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PTGER4—multiple sclerosis	4.51e-05	0.002	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PTGER4—multiple sclerosis	4.41e-05	0.00196	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CXCR3—multiple sclerosis	4.35e-05	0.00193	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CXCR3—multiple sclerosis	4.26e-05	0.00189	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CCL3—multiple sclerosis	4.25e-05	0.00189	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CCR2—multiple sclerosis	4.23e-05	0.00188	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CCL3—multiple sclerosis	4.16e-05	0.00185	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CCR2—multiple sclerosis	4.14e-05	0.00184	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PTGER4—multiple sclerosis	4.09e-05	0.00182	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—RGS1—multiple sclerosis	4.07e-05	0.00181	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PTGER4—multiple sclerosis	4e-05	0.00178	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—RGS1—multiple sclerosis	3.98e-05	0.00177	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CXCR3—multiple sclerosis	3.95e-05	0.00176	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CNR1—multiple sclerosis	3.91e-05	0.00174	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CXCR3—multiple sclerosis	3.87e-05	0.00172	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GPR65—multiple sclerosis	3.85e-05	0.00171	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CCR2—multiple sclerosis	3.84e-05	0.00171	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CNR1—multiple sclerosis	3.82e-05	0.0017	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—POMC—multiple sclerosis	3.77e-05	0.00168	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GPR65—multiple sclerosis	3.77e-05	0.00168	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CCR2—multiple sclerosis	3.76e-05	0.00167	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—CCL2—multiple sclerosis	3.69e-05	0.00164	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—POMC—multiple sclerosis	3.69e-05	0.00164	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—CCL2—multiple sclerosis	3.61e-05	0.00161	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CNR1—multiple sclerosis	3.55e-05	0.00158	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CXCL13—multiple sclerosis	3.52e-05	0.00157	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCR1—multiple sclerosis	3.52e-05	0.00157	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CXCL10—multiple sclerosis	3.52e-05	0.00156	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CNR1—multiple sclerosis	3.47e-05	0.00154	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CXCL13—multiple sclerosis	3.45e-05	0.00153	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCR1—multiple sclerosis	3.45e-05	0.00153	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CXCL10—multiple sclerosis	3.44e-05	0.00153	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CXCL10—multiple sclerosis	3.19e-05	0.00142	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CXCL10—multiple sclerosis	3.13e-05	0.00139	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CCL5—multiple sclerosis	3.03e-05	0.00135	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CCL5—multiple sclerosis	2.96e-05	0.00132	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CCL5—multiple sclerosis	2.75e-05	0.00122	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CCR5—multiple sclerosis	2.73e-05	0.00121	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CCL5—multiple sclerosis	2.69e-05	0.0012	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—IL2RA—multiple sclerosis	2.69e-05	0.0012	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CCR5—multiple sclerosis	2.67e-05	0.00119	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—IL2RA—multiple sclerosis	2.63e-05	0.00117	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCL3—multiple sclerosis	2.51e-05	0.00112	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CCR5—multiple sclerosis	2.48e-05	0.0011	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCL3—multiple sclerosis	2.46e-05	0.00109	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—IL2RA—multiple sclerosis	2.44e-05	0.00109	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CCR5—multiple sclerosis	2.42e-05	0.00108	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PTGER4—multiple sclerosis	2.42e-05	0.00107	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—IL2RA—multiple sclerosis	2.39e-05	0.00106	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PGR—multiple sclerosis	2.38e-05	0.00106	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PTGER4—multiple sclerosis	2.36e-05	0.00105	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CXCR3—multiple sclerosis	2.33e-05	0.00104	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PGR—multiple sclerosis	2.33e-05	0.00104	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CD28—multiple sclerosis	2.31e-05	0.00103	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CXCR3—multiple sclerosis	2.28e-05	0.00102	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCR2—multiple sclerosis	2.27e-05	0.00101	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CD28—multiple sclerosis	2.26e-05	0.00101	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCR2—multiple sclerosis	2.22e-05	0.000988	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—POMC—multiple sclerosis	2.13e-05	0.000948	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CNR1—multiple sclerosis	2.1e-05	0.000932	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—POMC—multiple sclerosis	2.09e-05	0.000927	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CNR1—multiple sclerosis	2.05e-05	0.000911	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—POMC—multiple sclerosis	1.94e-05	0.000861	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CCL2—multiple sclerosis	1.89e-05	0.000842	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—POMC—multiple sclerosis	1.89e-05	0.000842	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CXCL10—multiple sclerosis	1.89e-05	0.000839	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CCL2—multiple sclerosis	1.85e-05	0.000824	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CXCL10—multiple sclerosis	1.85e-05	0.000821	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—TYK2—multiple sclerosis	1.72e-05	0.000765	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—TYK2—multiple sclerosis	1.68e-05	0.000748	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CD86—multiple sclerosis	1.65e-05	0.000733	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCL5—multiple sclerosis	1.62e-05	0.000722	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CD86—multiple sclerosis	1.61e-05	0.000718	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCL5—multiple sclerosis	1.59e-05	0.000706	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—IL2—multiple sclerosis	1.58e-05	0.000701	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—IL2—multiple sclerosis	1.54e-05	0.000685	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SPP1—multiple sclerosis	1.5e-05	0.000669	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SPP1—multiple sclerosis	1.47e-05	0.000654	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCR5—multiple sclerosis	1.46e-05	0.000651	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IL2RA—multiple sclerosis	1.44e-05	0.000641	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCR5—multiple sclerosis	1.43e-05	0.000636	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—IL2—multiple sclerosis	1.43e-05	0.000636	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IL2RA—multiple sclerosis	1.41e-05	0.000627	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—IL2—multiple sclerosis	1.4e-05	0.000622	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—APOE—multiple sclerosis	1.33e-05	0.000592	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—APOE—multiple sclerosis	1.3e-05	0.000579	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CD80—multiple sclerosis	1.2e-05	0.000535	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CD80—multiple sclerosis	1.18e-05	0.000523	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—POMC—multiple sclerosis	1.14e-05	0.000508	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCL2—multiple sclerosis	1.12e-05	0.000497	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—POMC—multiple sclerosis	1.12e-05	0.000497	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—MAPK1—multiple sclerosis	1.1e-05	0.000487	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCL2—multiple sclerosis	1.09e-05	0.000487	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—MAPK1—multiple sclerosis	1.07e-05	0.000476	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TYK2—multiple sclerosis	1.02e-05	0.000452	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TYK2—multiple sclerosis	9.94e-06	0.000442	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IL2—multiple sclerosis	8.46e-06	0.000376	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—IL6—multiple sclerosis	8.41e-06	0.000374	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IL2—multiple sclerosis	8.27e-06	0.000368	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—IL6—multiple sclerosis	8.23e-06	0.000366	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MMP9—multiple sclerosis	8e-06	0.000356	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MMP9—multiple sclerosis	7.83e-06	0.000348	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—STAT3—multiple sclerosis	7.12e-06	0.000316	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—STAT3—multiple sclerosis	6.96e-06	0.000309	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MYC—multiple sclerosis	6.61e-06	0.000294	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TGFB1—multiple sclerosis	6.6e-06	0.000293	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MAPK1—multiple sclerosis	6.47e-06	0.000288	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MYC—multiple sclerosis	6.47e-06	0.000287	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TGFB1—multiple sclerosis	6.45e-06	0.000287	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MAPK1—multiple sclerosis	6.33e-06	0.000281	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IL6—multiple sclerosis	4.97e-06	0.000221	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IL6—multiple sclerosis	4.86e-06	0.000216	CbGpPWpGaD
